| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L) |
| 掲載誌名 | 正式名:JTO clinical and research reports 略 称:JTO Clin Res Rep ISSNコード:26663643 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 7,pp.101054 |
| 著者・共著者 | Yoshihiko Sakata, Kenta Murotani, Daichi Fujimoto, Yukihiro Toi, Toshihide Yokoyama, Seigo Katakura, Teppei Yamaguchi, Kaoru Tanaka, Satoru Miura, Motohiro Tamiya, Motoko Tachihara, Takehito Shukuya, Yuko Tsuchiya, Yuki Sato, Satoshi Ikeda, Shinya Sakata, Takeshi Masuda, Shinnosuke Takemoto, Hirotsugu Kenmotsu, Isamu Okamoto, Nobuyuki Yamamoto |
| 発行年月 | 2026/07 |
| DOI | 10.1016/j.jtocrr.2026.101054 |